Frontlight ResearchEarly access
CompletedNo phase
Assessment of Er:YAG Laser-Assisted Surgical Treatment in Medication-Related Osteonecrosis of the Jaw (MRONJ): A Clinical Trial
Key facts
- Who runs it
- Wroclaw Medical University
- Where
- Poland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 65 people enrolled
- Started
- 1 Feb 2021
- Ended
- 1 May 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- irradiation with Er:YAG laser
- Tissue preparation
- Record updated
- 19 June 2025
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- confirmed diagnosis of MRONJ
Who cannot take part
- head and neck radiotherapy
- cases requiring hospital admission due to poor general condition
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this study is assessing the effectiveness of the Er:YAG laser in relation to the use of conventional surgery in the treatment of drug-induced osteonecrosis of the jaws (MRONJ). The study compares two main treatments for advanced cases of MRONJ or cases that do not show improvement despite conservative or non-surgical treatment.
The 2 groups in the trial
- Patients treated with the Er:YAG laserTreatment being tested
Treatment: irradiation with Er:YAG laser
- Patients treated with the conventional surgeryExisting treatment, for comparison
Treatment: Tissue preparation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Assessment of Er:YAG (Yttrium-aluminium-garnet) Laser-Assisted Surgical Treatment in Medication-Related Osteonecrosis of the Jaw (MRONJ): A Clinical Trial
- Record updated
- 19 June 2025